2008 HCPCS Codes | Med Reference

Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).

https://medreference.org/i/q/medreference__hcpcs-codes?s=&h=&d=&o=&_n=25

Procedure

Description

Procedure: Calc bmi abv up param f/u
Description: Bmi is documented above normal parameters and a follow-up plan is documented

G8417

Procedure: Calc bmi blw low param f/u
Description: Bmi is documented below normal parameters and a follow-up plan is documented

G8418

Procedure: Calc bmi out nrm param nof/u
Description: Bmi documented outside normal parameters, no follow-up plan documented, no reason given

G8419

Procedure: Calc bmi norm parameters
Description: Bmi is documented within normal parameters and no follow-up plan is required

G8420

Procedure: Bmi not calculated
Description: Bmi not documented and no reason is given

G8421

Procedure: Pt inelig bmi calculation
Description: Bmi not documented, documentation the patient is not eligible for bmi calculation

G8422

Procedure: Docrev cur meds by elig clin
Description: Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications

G8427

Procedure: Cur meds not document
Description: Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given

G8428

Procedure: Ec at doc medrec pt not elig
Description: Eligible clinician attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible clinician

G8430

Procedure: Pos clin depres scrn f/u doc
Description: Screening for depression is documented as being positive and a follow-up plan is documented

G8431

Procedure: Dep scr not doc, rng
Description: Depression screening not documented, reason not given

G8432

Procedure: Scr for dep not cpt doc rsn
Description: Screening for depression not completed, documented reason

G8433

Procedure: Doc pain as nt perf, not elg
Description: Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter

G8442

Procedure: Beta-bloc rx pt w/abn lvef
Description: Beta-blocker therapy prescribed

G8450

Procedure: Pt w/abn lvef inelig b-bloc
Description: Beta-blocker therapy for lvef < 40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons, or other reasons attributable to the healthcare system)

G8451

Procedure: Pt w/abn lvef b-bloc no rx
Description: Beta-blocker therapy not prescribed

G8452

Procedure: Pt inelig geno no antvir tx
Description: Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)

G8458

Procedure: Pt inelig rna no antvir tx
Description: Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c

G8460

Procedure: Pt rec antivir treat hep c
Description: Patient receiving antiviral treatment for hepatitis c during the measurement period

G8461

Procedure: Pt inelig; lo to no dter rsk
Description: Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined

G8464

Procedure: High risk recurrence pro ca
Description: High or very high risk of recurrence of prostate cancer

G8465

Procedure: Ace/arb thxpy rx'd
Description: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed

G8473

Procedure: Ace/arb not rx'd; doc reas
Description: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons) or (e.g., lack of drug availability, other reasons attributable to the health care system)

G8474

Procedure: Ace/arb thxpy not rx'd
Description: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given

G8475

Procedure: Bp sys <140 and dias <90
Description: Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg

G8476

Procedure: Bp sys>=140 and/or dias >=90
Description: Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg

G8477

Procedure: Bp not performed/doc
Description: Blood pressure measurement not performed or documented, reason not given

G8478

Procedure: Flu immunize order/admin
Description: Influenza immunization administered or previously received

G8482

Procedure: Flu imm no admin doc rea
Description: Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

G8483

Procedure: Flu immunize no admin
Description: Influenza immunization was not administered, reason not given

G8484

Procedure: Report, diabetes measures
Description: I intend to report the diabetes mellitus (dm) measures group

G8485

Procedure: Report, prev care measures
Description: I intend to report the preventive care measures group

G8486

Procedure: Report ckd measures
Description: I intend to report the chronic kidney disease (ckd) measures group

G8487

Procedure: Hyalgan supartz visco-3 dose
Description: Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

J7321

Procedure: Euflexxa inj per dose
Description: Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose

J7323

Procedure: Orthovisc inj per dose
Description: Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose

J7324

Procedure: Policy criteria applied
Description: Policy criteria applied

Procedure: Esa, anemia, chemo-induced
Description: Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy

Procedure: Esa, anemia, radio-induced
Description: Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy

Procedure: Esa, anemia, non-chemo/radio
Description: Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy

Procedure: Hct>39% or hgb>13g>=3 cycle
Description: Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

Procedure: Hct>39% or hgb>13g<3 cycle
Description: Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

Procedure: Part credit, replaced device
Description: Partial credit received for replaced device

Procedure: Unit of service > mue value
Description: Units of service exceeds medically unlikely edit value and represents reasonable and necessary services

Procedure: Dmepos item, profession serv
Description: Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service

Procedure: Dmepos comp bid prgm no 4
Description: Dmepos item subject to dmepos competitive bidding program number 4

Procedure: Dmepos comp bid prgm no 5
Description: Dmepos item subject to dmepos competitive bidding program number 5

Procedure: Invest clinical research
Description: Investigational clinical service provided in a clinical research study that is in an approved clinical research study

Procedure: Routine clinical research
Description: Routine clinical service provided in a clinical research study that is in an approved clinical research study